Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine FormatsSAN LEANDRO, CA, Jan. 15, 2026 (GLOBE ...
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...
DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery System Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The transdermal drug delivery system ...
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...
The European Medicines Agency (EMA) has released two new draft guidelines on, respectively, the quality of oral modified release products and transdermal patches. The two draft guidance documents ...
XPhyto has outlined plans to move its rotigotine transdermal patch into a pivotal clinical trial. The Canadian company committed to further development of the rival to UCB’s Neupro after completing a ...
Again, the FDA does not regulate dietary or weight loss supplements, including weight loss patches. As a result, adverse side ...
VANCOUVER, BC / ACCESSWIRE / May 15, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has received government approval for to ...
Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback